CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Data monitoring for 48h within the first 12 hours of admission for COVID-19Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug2371 Rapid diagnostics using Anyplex TMII RV16 Detection Wiki 1.00
drug859 Delayed diagnostics Anyplex TMII RV16 Detection Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D005335 Fever of Unknown Origin NIH 1.00
D002637 Chest Pain NIH 1.00
D004417 Dyspnea NIH 0.35

Correlated HPO Terms (2)


Name (Synonyms) Correlation
HP:0100749 Chest pain HPO 1.00
HP:0002098 Respiratory distress HPO 0.35

There is one clinical trial.

Clinical Trials


1 Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)

One of the main challenges of the health crisis caused by the COVID-19 epidemic is the availability of beds in intensive care units (ICUs) and, more importantly, the need for invasive mechanical ventilation (IVM) because the ICUs are currently reserved for intubated patients. The experiences of both China and Italy indicate that a certain number of COVID-19 patients will require mechanical ventilation. However, the limited number of resuscitation beds and ventilators requires strict use of these scarce resources. As a significant proportion about 5% to 10%, of patients initially admitted to hospital with COVID-19 will require ventilation, it is essential to anticipate their need for resuscitation to improve the rare resource of beds and ventilator shortages in intensive care units. The hypothesis of the study is that, in proven or suspected hospitalised and oxygen-requiring COVID-19 patients, an early predictive clinical score, calculated over the three first days of admission may allow for an earlier identification of patients who will require intubation and transfer to an intensive care unit for orotracheal intubation

NCT04376879 COVID-19 Other: Data monitoring for 48h within the first 12 hours of admission for COVID-19

Primary Outcomes

Description: Primary outcome measure for the creation of the predictive score

Measure: the number of intubations in COVID-19 patients initially hospitalised in wards

Time: up to 1 month

Secondary Outcomes

Description: Secondary endpoints for validation of the predictive score

Measure: the number of intubations in COVID-19 patients initially hospitalised in wards.

Time: up to 1 month


No related HPO nodes (Using clinical trials)